LOCUS CELL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.55 TWD | -1.77% |
|
-3.32% | -3.02% |
| Jun. 26 | Locus Cell Co., Ltd. Appoints Kun-Ying, Tsai as Chief Operating Officer, Effective July 15, 2024 | CI |
| May. 24 | Locus Cell Co., Ltd. Announces Board Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LOCUS CELL CO., LTD. | Bio Therapeutic Drugs | -1.77% | -3.32% | -3.02% | -14.43% | - | 191M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- 6891 Stock
- Charts Locus Cell Co., Ltd.
- Comparison Chart
